Causes and predictive factors of mortality in a cohort of patients with hepatitis C virus-related cryoglobulinemic vasculitis treated with antiviral therapy | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Causes and predictive factors of mortality in a cohort of patients with hepatitis C virus-related cryoglobulinemic vasculitis treated with antiviral therapy

Landau DA, Scerra S, Sene D, Resche-Rigon M, Saadoun D, Cacoub P. Causes and predictive factors of mortality in a cohort of patients with hepatitis C virus-related cryoglobulinemic vasculitis treated with antiviral therapy. J Rheumatol. 2010;37(3):615-621.

Publication Type:

Journal Article

Authors:

Landau, D.A.; Scerra, S.; Sene, D.; Resche-Rigon, M.; Saadoun, D.; Cacoub, P.

Source:

J Rheumatol, Volume 37, Issue 3, p.615-621 (2010)

Keywords:

Aged, Aged,80 and over, analysis, Antiviral Agents, Carcinoma, Cause of Death, Central Nervous System, Cohort Studies, complications, Cryoglobulinemia, Death, Disease, drug therapy, Female, France, HCV, Hepacivirus, hepatitis, Hepatitis C, hepatitis C virus, history, Humans, Infection, interferon, Interferon Alfa-2a, Interferon-alpha, Kaplan-Meier Estimate, Liver, Male, methods, Middle Aged, Morbidity, Mortality, Paris, Patients, peginterferon, Polyethylene Glycols, Predictive Value of Tests, Prognosis, Proteins, Recombinant Proteins, Regression Analysis, Renal, Renal Insufficiency, Retrospective Studies, Ribavirin, Risk, Severity of Illness Index, Survivors, therapeutic use, therapy, treatment, ulcer, Vasculitis, Viral Load, virology

Cited On:

When and in Whom to Initiate HCV Therapy

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/20110523

Export Citation:

RIS Format

Top